Professor Ernest Choy
Projects as PI
- Advise Pfizer on the results and clinical interpretation of the CONDOR (Celecoxib versus omeprazole and diclofenac for at-risk osteroarthritis and rheumatoid arthritis patients at increased gastrointestinal (G) risk trial (01/07/2011 - 30/11/2011)
- A global comparative observational study in Rheumatoid Arthritis (RA) patients who are treated with TNF inhibitor or Tocilizumab as a first biological treatment (01/05/2012 - 30/04/2013)
- A randomised, phase 2 study to explore tolerability, safety, pharmacokinetics, pharmacodynamics and efficacy of intravenous infusions of NI-0101, an anti-toll like receptor 4 monoclonal antibody in patients with rheumatoid arthritis (21/09/2017 - 31/10/2018)
- Arthritis Research UK Treatment Centre (01/08/2012 - 30/09/2020)
- Assessment of a biosimilar product (Etanercept) - advisor (01/08/2012 - 31/08/2012)
Projects as Co-Investigator
- Automated 384-capacity real-time quantitative polymerase chain reaction (qPCR) facility (01/08/2012 - 31/07/2013)
- Centre for population health and wellbeing research (01/04/2015 - 31/03/2018)
- Centre for Population Health and Wellbeing Research (01/04/2015 - 31/03/2018)
- Centre for Population Health and Wellbeing Research (01/04/2018 - 31/03/2020)
- Defining the efficacy and potency of FE-999301 in experimental inflammatory arthritis (11/03/2013 - 31/05/2014)